“The downgrade is primarily driven by the district’s somewhat economically limited service area,” said S&P analyst Jennifer Garza. “Although financial performance is adequate in our view, the district’s liquidity position is weaker than that of its peers.”
The outlook is stable, reflecting S&P’s view of the district’s tax-revenue flexibility and solid market position.
More articles on healthcare finance:
S&P assigns ‘A’ rating to Wake Forest Baptist Medical Center’s bonds
Medicare and Medicaid HIV spending continues to rise: 11 things to know
9 things to know about CMS’ cancer care model
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
